Adagene Net Income From Continuing Ops from 2010 to 2026
| ADAG Stock | USD 2.91 0.14 5.05% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -30.1 M | Current Value -31.6 M | Quarterly Volatility 20.2 M |
Check Adagene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adagene's main balance sheet or income statement drivers, such as Net Interest Income of 3.6 M, Interest Income of 4.6 M or Depreciation And Amortization of 1.1 M, as well as many indicators such as Price To Sales Ratio of 767, Dividend Yield of 0.0 or PTB Ratio of 1.34. Adagene financial statements analysis is a perfect complement when working with Adagene Valuation or Volatility modules.
Adagene | Net Income From Continuing Ops | Build AI portfolio with Adagene Stock |
The Net Income From Continuing Ops trend for Adagene offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Adagene is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Adagene's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Adagene over the last few years. It is Adagene's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adagene's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Adagene Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (25,732,236) | |
| Coefficient Of Variation | (78.39) | |
| Mean Deviation | 14,068,258 | |
| Median | (15,266,184) | |
| Standard Deviation | 20,171,524 | |
| Sample Variance | 406.9T | |
| Range | 64.7M | |
| R-Value | (0.49) | |
| Mean Square Error | 330T | |
| R-Squared | 0.24 | |
| Significance | 0.05 | |
| Slope | (1,955,074) | |
| Total Sum of Squares | 6510.2T |
Adagene Net Income From Continuing Ops History
About Adagene Financial Statements
Adagene stakeholders use historical fundamental indicators, such as Adagene's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Adagene investors may analyze each financial statement separately, they are all interrelated. For example, changes in Adagene's assets and liabilities are reflected in the revenues and expenses on Adagene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Adagene. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -30.1 M | -31.6 M |
Currently Active Assets on Macroaxis
When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:Check out the analysis of Adagene Correlation against competitors. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Can Biotechnology industry sustain growth momentum? Does Adagene have expansion opportunities? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Adagene demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.64) | Revenue Per Share | Quarterly Revenue Growth (0.87) | Return On Assets | Return On Equity |
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Adagene's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adagene represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Adagene's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.